Market Pricing
Understanding the Global Supply Chain Constraints of GLP-1 Medications
An in-depth look at the manufacturing bottlenecks causing ongoing shortages of GLP-1 therapies and what it means for patient access in 2026.
Market Pricing
Clinical Science
The Impact of GLP-1 Receptor Agonists on Sleep Apnea: A New Frontier
Recent clinical data highlights the potential of GLP-1 medications to significantly improve Obstructive Sleep Apnea (OSA) severity, expanding their role in comprehensive metabolic care.
Clinical Science
Beyond Weight Loss: The Cardiovascular and Metabolic Revolution of GLP-1 Receptor Agonists
Exploring the profound cardiovascular and metabolic benefits of GLP-1 receptor agonists beyond weight loss.
Patient Safety
Navigating GLP-1 Side Effects: A Practical Guide for Patients
A comprehensive guide to managing the common gastrointestinal side effects of GLP-1 medications and strategies to preserve lean muscle mass during treatment.
Clinical Science
Beyond Weight Loss: The Cardiovascular Benefits of GLP-1 Receptor Agonists
Recent studies reveal that GLP-1 receptor agonists offer significant cardiovascular protection independent of weight loss, shifting the paradigm in preventative cardiology.
Clinical Science
Beyond Weight Loss: The Cardiovascular Paradigm Shift of GLP-1 Receptor Agonists
Exploring the paradigm shift of GLP-1 receptor agonists from weight loss and diabetes management to potent cardiovascular risk reduction based on landmark clinical trials.
Patient Safety
Gastroparesis on GLP-1s: A Quiet Safety Signal Patients Deserve to Hear About
Reports of stomach paralysis linked to semaglutide and tirzepatide are rising. Here is what the published evidence actually shows, who is at higher risk, and what proper monitoring looks like.
Sponsored · Teleios Health
The $99 physician-led GLP-1 program
Board-certified physicians, quarterly labs, muscle-preserving protocols, supplement Rx, and resistance training guidance — all included.
See the Program →